LM Funding America (LMFA) had the highest return between November 1, 2015 and December 31, 2015 by a US stock, returning 8,979,698%.
| ASSET | DATE | % RETURN |
|---|---|---|
LM Funding America (LMFA) | 11/1/2015 - 12/31/2015 | 8,979,697.98% |
MDxHealth SA ADR (MDXH) | 11/1/2015 - 12/31/2015 | 780% |
Zynex (ZYXI) | 11/1/2015 - 12/31/2015 | 206.66% |
Ambow Education (AMBO) | 11/1/2015 - 12/31/2015 | 146.91% |
Lincoln Educational Services (LINC) | 11/1/2015 - 12/31/2015 | 123.57% |
Scienture (SCNX) | 11/1/2015 - 12/31/2015 | 115.52% |
The9 Ltd ADR (NCTY) | 11/1/2015 - 12/31/2015 | 112.84% |
COSCIENS Biopharma (CSCI) | 11/1/2015 - 12/31/2015 | 111.4% |
Constellium (CSTM) | 11/1/2015 - 12/31/2015 | 104.24% |
Versus Systems Inc. (VS) | 11/1/2015 - 12/31/2015 | 104.23% |
Five9 (FIVN) | 11/1/2015 - 12/31/2015 | 102.33% |
Insight Molecular Diagnostics (IMDX) | 11/1/2015 - 12/31/2015 | 101.61% |
Workhorse (WKHS) | 11/1/2015 - 12/31/2015 | 98.72% |
CytomX Therapeutics (CTMX) | 11/1/2015 - 12/31/2015 | 92.53% |
CervoMed (CRVO) | 11/1/2015 - 12/31/2015 | 92.31% |
Aclaris Therapeutics (ACRS) | 11/1/2015 - 12/31/2015 | 89.45% |
LightPath Technologies (LPTH) | 11/1/2015 - 12/31/2015 | 88.67% |
Pacific Biosciences of California (PACB) | 11/1/2015 - 12/31/2015 | 85.45% |
Lixte Biotechnology (LIXT) | 11/1/2015 - 12/31/2015 | 84.38% |
Dyadic International (DYAI) | 11/1/2015 - 12/31/2015 | 82.83% |
Nixxy (NIXX) | 11/1/2015 - 12/31/2015 | 80.95% |
ReWalk Robotics (LFWD) | 11/1/2015 - 12/31/2015 | 79.53% |
Taoping (TAOP) | 11/1/2015 - 12/31/2015 | 76.84% |
Idaho Strategic Resources (IDR) | 11/1/2015 - 12/31/2015 | 76.47% |
TherapeuticsMD (TXMD) | 11/1/2015 - 12/31/2015 | 76.36% |
